Project Details
| Status | Active |
|---|---|
| Effective start/end date | 5/26/17 → 8/31/50 |
Funding
- bluebird bio, Inc.
HGB-212: A Phase 3 Single Arm Study Evaluating the Efficacy and Safety of Gene Therapy in Subjects with Transfusion-dependent ?-Thalassemia, who have a B0/B0 Genotype, by Transplantation of Autologous CD34+ Stem Cells Transduce
- Thompson, Alexis A (PD/PI)
Project: Research project